(FRSX) Foresight Autonomous - Ratings and Ratios
Exchange: NASDAQ • Country: Israel • Currency: USD • Type: Common Stock • ISIN: US3455231049
FRSX: Vision Systems, Obstacle Detection, Calibration Software, 3D Sensing, V2X
Foresight Autonomous Holdings Ltd. (NASDAQ:FRSX) is a technology company specializing in advanced vision and sensing solutions for the automotive industry. Headquartered in Ness Ziona, Israel, the company develops and commercializes cutting-edge, multi-spectral 3D vision software and hardware for obstacle detection, accident prevention, and autonomous systems. Its product portfolio includes QuadSight, a four-camera system combining infrared and visible-light stereoscopic cameras for enhanced obstacle detection; DynamiCal, an automatic calibration solution ensuring accurate 3D depth perception; and ScaleCam, a separated stereo camera system for flexible deployment. Additionally, the company offers Percept3D for 3D point cloud generation, Mono2Stereo for enhancing 2D vision systems, and Eye-Net Protect, a cellular-based V2X solution for real-time collision alerts. These solutions cater to automotive, defense, agriculture, and industrial equipment industries. Foresight Autonomous Holdings Ltd. was formerly known as Asia Development (A.D.B.M.) Ltd. and rebranded in January 2016. For more information, visit https://www.foresightauto.com.
3-Month Forecast: Based on technical and fundamental data, FRSX is expected to remain volatile with potential price fluctuations within the $0.50-$1.00 range. The stock may face resistance at $1.00 and support at $0.50. The relative strength index (RSI) is likely to oscillate between 30 and 70, indicating a neutral to oversold condition. The average true range (ATR) of 0.12 suggests moderate price movement. Fundamental analysis highlights a high P/S ratio of 27.13, indicating growth potential but also elevated valuations relative to sales. The P/B ratio of 1.57 suggests the market is pricing in future growth prospects. Overall, FRSX is likely to remain a speculative play with upside tied to commercialization progress and market adoption of its vision-based solutions.
Additional Sources for FRSX Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
FRSX Stock Overview
| Market Cap in USD | 11m |
| Sector | Consumer Cyclical |
| Industry | Auto Parts |
| GiC Sub-Industry | Automotive Parts & Equipment |
| IPO / Inception | 2017-06-15 |
FRSX Stock Ratings
| Growth 5y | -74.3% |
| Fundamental | - |
| Dividend | 0.0% |
| Rel. Strength Industry | -32.8 |
| Analysts | 5/5 |
| Fair Price Momentum | 0.53 USD |
| Fair Price DCF | - |
FRSX Dividends
No Dividends PaidFRSX Growth Ratios
| Growth Correlation 3m | -53.8% |
| Growth Correlation 12m | -36.8% |
| Growth Correlation 5y | -87.4% |
| CAGR 5y | -25.17% |
| CAGR/Max DD 5y | -0.25 |
| Sharpe Ratio 12m | -2.06 |
| Alpha | -36.11 |
| Beta | 0.32 |
| Volatility | 109.11% |
| Current Volume | 121.7k |
| Average Volume 20d | 130.1k |
As of March 18, 2025, the stock is trading at USD 0.71 with a total of 121,657 shares traded.
Over the past week, the price has changed by +3.48%, over one month by -23.62%, over three months by +12.46% and over the past year by -25.63%.
No, based on ValueRay Analyses, Foresight Autonomous (NASDAQ:FRSX) is currently (March 2025) a stock to sell. It has a ValueRay Growth Rating of -74.33 and therefor a clear technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of FRSX as of March 2025 is 0.53. This means that FRSX is currently overvalued and has a potential downside of -25.35%.
Foresight Autonomous has received a consensus analysts rating of 5.00. Therefor, it is recommend to buy FRSX.
- Strong Buy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, FRSX Foresight Autonomous will be worth about 0.6 in March 2026. The stock is currently trading at 0.71. This means that the stock has a potential downside of -19.72%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 24 | 3280.3% |
| Analysts Target Price | 24 | 3280.3% |
| ValueRay Target Price | 0.6 | -19.7% |